237 related articles for article (PubMed ID: 16465612)
21. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
[TBL] [Abstract][Full Text] [Related]
22. [Histopathological study on the process of joint destruction in rheumatoid arthritis].
Itoh Y; Takahashi Y; Sawai T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():96-9. PubMed ID: 15799325
[No Abstract] [Full Text] [Related]
23. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
[TBL] [Abstract][Full Text] [Related]
24. Synovial fluid macrophages are capable of osteoclast formation and resorption.
Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
[TBL] [Abstract][Full Text] [Related]
25. [Mechanism of the bone destruction in rheumatoid arthritis].
Nakamura M; Tanaka S
Nihon Rinsho; 2005 Sep; 63(9):1571-3. PubMed ID: 16164213
[TBL] [Abstract][Full Text] [Related]
26. Structural, cellular, and molecular evaluation of bone erosion in experimental models of rheumatoid arthritis: assessment by μCT, histology, and serum biomarkers.
Chao CC; Chen SJ; Adamopoulos IE; Judo M; Asio A; Ayanoglu G; Bowman EP
Autoimmunity; 2010 Dec; 43(8):642-53. PubMed ID: 20380588
[TBL] [Abstract][Full Text] [Related]
27. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
28. [Possible roles of TNF family cytokines in bone destruction of rheumatoid arthritis].
Udagawa N; Kotake S; Kamatani N; Takahashi N; Suda T
Ryumachi; 2002 Feb; 42(1):3-12. PubMed ID: 11925905
[No Abstract] [Full Text] [Related]
29. Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor.
Yuan X; Tong B; Dou Y; Wu X; Wei Z; Dai Y
Biochem Pharmacol; 2016 Feb; 101():87-99. PubMed ID: 26640276
[TBL] [Abstract][Full Text] [Related]
30. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis.
Orosa B; García S; Martínez P; González A; Gómez-Reino JJ; Conde C
Ann Rheum Dis; 2014 Jan; 73(1):298-305. PubMed ID: 23486415
[TBL] [Abstract][Full Text] [Related]
32. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
33. Focal bone involvement in inflammatory arthritis: the role of IL17.
Rossini M; Viapiana O; Adami S; Idolazzi L; Fracassi E; Gatti D
Rheumatol Int; 2016 Apr; 36(4):469-82. PubMed ID: 26521079
[TBL] [Abstract][Full Text] [Related]
34. [RANKL/RANK signaling in rheumatoid arthritis].
Omata Y; Tanaka S
Clin Calcium; 2011 Aug; 21(8):1175-80. PubMed ID: 21814022
[TBL] [Abstract][Full Text] [Related]
35. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
Edwards JR; Sun SG; Locklin R; Shipman CM; Adamopoulos IE; Athanasou NA; Sabokbar A
Arthritis Rheum; 2006 May; 54(5):1451-62. PubMed ID: 16649193
[TBL] [Abstract][Full Text] [Related]
36. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
Gravallese EM; Manning C; Tsay A; Naito A; Pan C; Amento E; Goldring SR
Arthritis Rheum; 2000 Feb; 43(2):250-8. PubMed ID: 10693863
[TBL] [Abstract][Full Text] [Related]
37. [RANKL/RANK signaling-inhibitor].
Aoki K; Ohya K
Nihon Rinsho; 2005 Sep; 63(9):1620-6. PubMed ID: 16164221
[TBL] [Abstract][Full Text] [Related]
38. Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis.
Herrak P; Görtz B; Hayer S; Redlich K; Reiter E; Gasser J; Bergmeister H; Kollias G; Smolen JS; Schett G
Arthritis Rheum; 2004 Jul; 50(7):2327-37. PubMed ID: 15248234
[TBL] [Abstract][Full Text] [Related]
39. Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis.
Komatsu N; Win S; Yan M; Huynh NC; Sawa S; Tsukasaki M; Terashima A; Pluemsakunthai W; Kollias G; Nakashima T; Takayanagi H
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720039
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation.
Hirayama T; Dai S; Abbas S; Yamanaka Y; Abu-Amer Y
Arthritis Rheum; 2005 Sep; 52(9):2719-29. PubMed ID: 16142755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
